Hyperion Therapeutics IPO Criticized for Poor Corporate Governance by UNITEHERE – Business Wire

July 23, 2012 Posted By: Leave a comment
NEW YORK--(BUSINESS WIRE)--UNITEHERE Research criticized Hyperion Therapeutics (NASDAQ: HPTX), which is undertaking an initial public offering, for weak corporate governance and a plethora ... Delaware General Corporation Law, or DGCL, could make it ...
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*

CAPTCHA Image

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>